Sir,
I read with interest the recent article by Murthy et al. [1] It provides excellent data regarding the management and outcome of patients with myasthenic crisis. I would like to make certain observations. First, Murthy et al have utilized the neostigmine test for confirmation of diagnosis. I would like to emphasize that the edrophonium (Tensilon) test is an excellent alternative for this purpose. It may even be better as the test result is obvious in 1-2 minutes, as compared to neostigmine that requires 15-30 minutes. Tensilon test has a relatively high sensitivity and specificity, [2] and the incidence of serious complications is only 0.16%. [3] Secondly, it is important to differentiate myasthenic crisis from cholinergic crisis. The edrophonium test allows for this differentiation and this may help in optimizing the treatment.
Thirdly, Murthy et al started all their patients on steroids prior to discharge. We agree with the approach, however, caution is required as steroids may exacerbate weakness in a subgroup of patients with myasthenia. Therefore, it is advisable to keep patients hospitalized after initiating steroids till clinical improvement begins, as exacerbations after that are unusual.
Finally, Murthy et al have shown the effectiveness of lowvolume plasma exchanges in myasthenic crisis, which is similar to our observations. [4] It is particularly important in the Indian scenario to minimize the cost of treatment. It is encouraging to note that plasmapheresis was shown to be superior to intravenous immunoglobulins in treating myasthenic crisis in an earlier study.
We thank Kumar and colleagues for his interest in our article published in the March issue of the journal.
[1] All the patients were established cases of myasthenia gravis (MG) under follow up in our clinic. The initial diagnosis in the patients was established by neostigmine test and decrement response. This has been stated in the material and methods. We had not used neostigmine to establish the diagnosis of myasthenic crisis in our series. We are very much aware of the safety and superiority of edrophonium over neostigmine, unfortunately the availability is a major limiting factor. A cholinergic crisis is less common than presumed and combination of both crises is often clinically encountered as seen in one of the patients in our series. [2] Steroids were started in all the patients after disease stabilization while they were in the hospital. The initiation to steroids was gradual. Worsening with high-dose steroid occurs 7-14 days after initiation of the high doses and usually lasts less than 1 week. It appears that gradually increasing the dose of steroids over a period reduces the risk of the early worsening of the disease. [3] In patients with MG uncontrolled studies, plasma exchange (PE) have demonstrated efficacy with the onset of improvement within the first week.
[4], [5] Randomized controlled studies comparing PE with intravenous immunoglobulin (IVIg) have demonstrated equal efficacy, but significantly fewer and less severe side effects for the IVIg.
[6], [7] The data on the efficacy of both these immunomodulators in myasthenic crisis are limited. In a retrospective multicenter study PE (compared with IVIg) was associated with a superior ventilatory status at 2-week and 1-month functional outcome. However, the complication rate was higher with PE compared with IVIg.
